Traws Pharma, Inc.

This study is testing whether a new drug called ratutrelvir, when given alongside standard COVID-19 treatment, is safe and helps people recover faster from mild to moderate COVID-19. The trial will enroll 90 adults who have had COVID-19 symptoms for less than 5 days and don't req…